Skip to main content
OpenTrials

Clinical trial condition

Non-obstructive Hypertrophic Cardiomyopathy

Explore clinical trials studying Non-obstructive Hypertrophic Cardiomyopathy. Study availability and eligibility vary by location and protocol.

8 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Non-obstructive Hypertrophic Cardiomyopathy trial results

Recruiting

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

NCT07023614

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • Imbria Investigational Site La Jolla, California, United States
  • Imbria Investigational Site Los Angeles, California, United States
  • Imbria Investigational Site San Francisco, California, United States
  • Imbria Investigational Site Washington D.C., District of Columbia, United States
View all 67 locations
View Trial Details
Recruiting

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy

NCT05569382

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +6 more
Locations
  • Department of Cardiology, Aarhus University Hospital Aarhus N, Denmark
  • Department of Cardiology, Odense University Hospital Odense, Denmark
  • Department of Cardiology, Zealand University Hospital Roskilde, Denmark
  • Department of Cardiology, Regional Hospital Viborg Viborg, Denmark
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

NCT06481891

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +7 more
Locations
  • Lexicon Investigational Site (4041) Phoenix, Arizona, United States
  • Lexicon Investigational Site (4037) Scottsdale, Arizona, United States
  • Lexicon Investigational Site (4012) Los Angeles, California, United States
  • Lexicon Investigational Site (4035) Pomona, California, United States
View all 108 locations
View Trial Details
Completed

A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM

NCT03723655

Conditions
Aortic Stenosis, Subvalvular, Aortic Valve Disease, Aortic Valve Stenosis, +8 more
Locations
  • Local Institution - 0045 Scottsdale, Arizona, United States
  • Local Institution - 0058 Los Angeles, California, United States
  • Local Institution - 0066 San Francisco, California, United States
  • Local Institution - 0063 Stanford, California, United States
View all 68 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial

NCT04826185

Conditions
Non-obstructive Hypertrophic Cardiomyopathy
Locations
  • Imbria Investigational Site La Jolla, California, United States
  • Imbria Investigational Site Los Angeles, California, United States
  • Imbria Investigational Site San Francisco, California, United States
  • Imbria Investigational Site Chicago, Illinois, United States
View all 14 locations
View Trial Details
Completed

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

NCT03442764

Conditions
Non-obstructive Hypertrophic Cardiomyopathy
Locations
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Cedars-Sinai Medical Center (Smidt Heart Institute) Los Angeles, California, United States
  • Stanford Hospital and Clinics/Stanford University Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 32 locations
View Trial Details

Related conditions